|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
17
|
|
pubmed:dateCreated |
2005-11-1
|
|
pubmed:abstractText |
Antiretroviral therapy (ART) containing tenofovir disoproxil fumarate (TDF) and didanosine (ddI) has been associated with poor immune recovery despite virologic success. This effect might be related to ddI toxicity since ddI exposure is substantially increased by TDF.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0269-9370
|
|
pubmed:author |
pubmed-author:BattegayManuelM,
pubmed-author:CavassiniMatthiasM,
pubmed-author:ElziLuigiaL,
pubmed-author:FurrerHansjakobH,
pubmed-author:Gayet-AgeronAngèleA,
pubmed-author:HirschelBernardB,
pubmed-author:KarrerUrsU,
pubmed-author:LedergerberBrunoB,
pubmed-author:RussottiMarinaM,
pubmed-author:SchmidPatrickP,
pubmed-author:SpeckRoberto FRF,
pubmed-author:Swiss HIV Cohort Study,
pubmed-author:WeberRainerR
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
18
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1987-94
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16260905-Adenine,
pubmed-meshheading:16260905-Adult,
pubmed-meshheading:16260905-CD4 Lymphocyte Count,
pubmed-meshheading:16260905-Didanosine,
pubmed-meshheading:16260905-Dose-Response Relationship, Immunologic,
pubmed-meshheading:16260905-Drug Administration Schedule,
pubmed-meshheading:16260905-Drug Therapy, Combination,
pubmed-meshheading:16260905-Female,
pubmed-meshheading:16260905-HIV Infections,
pubmed-meshheading:16260905-Humans,
pubmed-meshheading:16260905-Male,
pubmed-meshheading:16260905-Middle Aged,
pubmed-meshheading:16260905-Phosphonic Acids,
pubmed-meshheading:16260905-RNA, Viral,
pubmed-meshheading:16260905-Retrospective Studies,
pubmed-meshheading:16260905-Reverse Transcriptase Inhibitors,
pubmed-meshheading:16260905-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovir.
|
|
pubmed:affiliation |
Division of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich, Switzerland. urs.karrer@usz.ch
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
